Neulasta - pegfilgrastim
Navigation: NDC > Supplier starting with: A > AMGEN INC| Field | Value |
|---|---|
| NDC Code: | 55513-190 |
| Proprietary Name: | Neulasta |
| Suffix: | |
| Non-Proprietary Name: | pegfilgrastim |
| Dosage Form: | INJECTION |
| Method: | SUBCUTANEOUS |
| Original Marketing Date: | 01-04-2002 |
| Category Name: | BLA |
| Application Number: | BLA125031 |
| Labeler: | AMGEN INC |
| Substance Name: | PEGFILGRASTIM |
| Active Numerator Strength: | 6 |
| Active Ingredient Unit: | mg/.6mL |
| Pharm Classes: | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
| DEA Schedule: |